Crossmark

What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?

Crossref DOI link: https://doi.org/10.14283/jpad.2023.74

Published Print: 2023-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Doody, Rachelle S.

Skerjanec, S.
License Information

Text and Data Mining valid from 2023-09-01

Text and Data Mining valid from 2023-09-01

Version of Record valid from 2024-09-20
More Information

This article is maintained by: Elsevier

Article Title: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2023.74

Content Type: article

Copyright: Copyright © 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS